-
摘要: 长链非编码RNAs（long noncoding RNAs，lncRNAs）是长度≥200个核苷酸的非蛋白编码转录子。多数lncRNAs在肿瘤组织中显示致癌基因的作用，通过影响肿瘤细胞的增生、迁移、浸润和转移促进肿瘤的发生发展；部分lncRNAs已成为特定肿瘤的诊断及预后标志物。对其表达、功能及机制的研究成为当前肿瘤研究的热点，但多集中于上皮源性肿瘤。本文旨在对lncRNAs在淋巴造血系统肿瘤中的研究进展进行综述。Abstract: Long noncoding RNAs (lncRNAs) are non-protein coding transcripts longer than 200 nucleotides. Most lncRNAs have pronounced oncogenic effects associated with tumorigenesis and progression, promoting the proliferation, migration, invasion, and metastasis of tumor cells. The specific lncRNAs expression in particular types of cancers makes them promising diagnostic and prognostic biomarkers. Currently, studies on lncRNAs expression, functions, and mechanisms have attracted considerable attention in cancer research. However, these studies mainly focus on epitheliogenic malignant tumors. In this review, we outline the current state of information on lncRNAs and research progress on its role in haematopoietic and lymphoid tissue tumors.
-
[1] Mattick JS. Non-coding RNAs: the architects of eukaryotic complexity[J]. EMBO Rep, 2001 (11):986-991. https://www.researchgate.net/publication/11642444_Non-coding_RNAs_the_architects_of_eukaryotic_complexity [2] Cao JN. The functional role of long non-coding RNAs and epigenetics[J]. Biol Proced Online, 2014, 16(1):11. doi: 10.1186/1480-9222-16-11 [3] Huarte M. The emerging role of lncRNAs in cancer[J]. Nat Med, 2015, 21(11):1253-1261. doi: 10.1038/nm.3981 [4] Novikova IV, Hennelly SP, Sanbonmatsu KY. Structural architecture of the human long non-coding RNA, steroid receptor RNA activator [J]. Nucleic Acids Res, 2012, 40(11):5034-5051. doi: 10.1093/nar/gks071 [5] Alam T, Medvedeva YA, Jia H, et al. Promoter analysis reveals globally differential regulation of human long Non-Coding RNA and protein-coding genes[J]. PLoS One, 2014, 9(10):e109443. doi: 10.1371/journal.pone.0109443 [6] Batista PJ, Chang HY. Long noncoding RNAs: cellular address codes in development and disease[J]. Cell, 2013, 152(6):1298-1307. doi: 10.1016/j.cell.2013.02.012 [7] Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways [J]. Cancer Cell, 2016, 29(4):452-463. doi: 10.1016/j.ccell.2016.03.010 [8] Rinn JL, Kertesz M, Wang JK, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs[J]. Cell, 2007, 129(7):1311-1323. doi: 10.1016/j.cell.2007.05.022 [9] Alvarez-Dominguez JR, Hu WQ, Gromatzky AA, et al. Long noncoding RNAs during normal and malignant hematopoiesis[J]. Int J Hematol, 2014, 99(5):531-541. doi: 10.1007/s12185-014-1552-8 [10] Cesana M, Cacchiarelli D, Legnini I, et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA[J]. Cell, 2011, 147(2):358-369. doi: 10.1016/j.cell.2011.09.028 [11] Pan Y, Li HX, Guo Y, et al. A pilot study of long noncoding RNA expression profiling by microarray in follicular lymphoma[J]. Gene, 2016, 577(2):132-139. doi: 10.1016/j.gene.2015.11.029 [12] Verma A, Jiang YW, Du W, et al. Transcriptome sequencing reveals thousands of novel long non-coding RNAs in B cell lymphoma[J]. Genome Med, 2015, 7(1):110. doi: 10.1186/s13073-015-0230-7 [13] Tseng YY, Moriarity BS, Gong W, et al. PVT1 dependence in cancer with MYC copy-number increase[J]. Nature, 2014, 512(7512):82-86. http://adsabs.harvard.edu/abs/2014Natur.512...82T [14] Doose G, Haake A, Bernhart SH, et al. MINCR is a MYC-induced lncRNA able to modulate MYC's transcriptional network in Burkitt lymphoma cells[J]. Proc Natl Acad Sci USA, 2015, 112(38):e5261-5270. doi: 10.1073/pnas.1505753112 [15] Lee CS, Ungewickell A, Bhaduri A, et al. Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts[J]. Blood, 2012, 120(16): 3288-3297. doi: 10.1182/blood-2012-04-423061 [16] Tayari MM, Winkle M, Kortman GA, et al. Long noncoding RNA expression profiling in normal B-Cell subsets and hodgkin lymphoma reveals hodgkin and Reed-Sternberg cell specific long noncoding RNAs[J]. Am J Path, 2016, 186(9):2462-2472. doi: 10.1016/j.ajpath.2016.05.011 [17] Isin M, Ozgur E, Cetin G, et al. Investigation of circulating lncRNAs in B-cell neoplasms[J]. Clin Chim Acta, 2014, 431(3):255-259. https://www.researchgate.net/publication/260445056_Investigation_of_Circulating_LncRNAs_in_B-cell_Neoplasms [18] Rodríguez-Malavé NI, Fernando TR, Patel PC, et al. BALR-6 regulates cell growth and cell survival in B-lymphoblastic leukemia[J]. Mol Cancer, 2015, 14(1):214. doi: 10.1186/s12943-015-0485-z [19] Hessels D, Gunnewiek JM, Van Oort I, et al. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer[J]. Eur Urol, 2003, 44(1):8-15. doi: 10.1016/S0302-2838(03)00201-X [20] Lee GL, Dobi A, Srivastava S. Prostate cancer:diagnostic performance of the PCA3 urine test[J]. Nat Rev Urol, 2011, 8(3):123-124. doi: 10.1038/nrurol.2011.10 [21] Arita T, Ichikawa D, Konishi H, et al. Circulating long non-coding RNAs in plasma of patients with gastric cancer[J]. Anticancer Res, 2013, 33(8):3185-3193. https://www.researchgate.net/publication/253340124_Circulating_Long_Non-coding_RNAs_in_Plasma_of_Patients_with_Gastric_Cancer [22] Zhou X, Yin C, Dang Y, et al. Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer[J]. Sci Rep, 2015, 5(2):11516. https://www.researchgate.net/profile/Xiaoying_Zhou8/publication/280032715_Identification_of_the_long_non-coding_RNA_H19_in_plasma_as_a_novel_biomarker_for_diagnosis_of_gastric_cancer/links/55ed8e7908aeb6516268ea57.pdf [23] Wang XS, Zhang Z, Wang HC, et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma[J]. Clin Cancer Res, 2006, 12(16):4851-4858. doi: 10.1158/1078-0432.CCR-06-0134 [24] Xie H, Ma H, Zhou D. Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma[J]. Biomed Res Int, 2013, 2013(23):136106. https://www.researchgate.net/publication/237200909_Plasma_HULC_as_a_Promising_Novel_Biomarker_for_the_Detection_of_Hepatocellular_Carcinoma/fulltext/02e0c0d20cf2fd9c23752080/237200909_Plasma_HULC_as_a_Promising_Novel_Biomarker_for_the_Detection_of_Hepatocellular_Carcinoma.pdf?origin=publication_detail [25] Peng W, Feng JF. Long noncoding RNA LUNAR1 associates with cell proliferation and predicts a poor prognosis in diffuse large B-cell lymphoma[J]. Biomed & Pharmaco, 2016, 77(3):65-71. https://www.researchgate.net/publication/287505459_Long_noncoding_RNA_LUNAR1_associates_with_cell_proliferation_and_predicts_a_poor_prognosis_in_diffuse_large_B-cell_lymphoma?_sg=YqpFdtHPN4Cc1dluomF8wiCPZJvU4KlBgFcy5LAm5EJUvitA2l-Bs1kVgo_Oug2Nq5SbGDHnQCMHOvoMPK5AuA [26] Gutschner T, Hämmerle M, Eissmann M, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells[J]. Cancer Res, 2013, 73(3):1180-1189. doi: 10.1158/0008-5472.CAN-12-2850 [27] Qiao HP, Gao WS, Huo JX, et al. Long non-coding RNA GAS5 functions as a tumor suppressor in renal cell carcinoma[J]. Asian Pac J Cancer Prev, 2013, 14(2):1077-1082. doi: 10.7314/APJCP.2013.14.2.1077 [28] Sun M, Jin FY, Xia R, et al. Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer[J]. BMC Cancer, 2014, 14(1):1-12. doi: 10.1186/1471-2407-14-1 [29] Ideue T, Hino K, Kitao S, et al. Efficient oligonucleotide-mediated degradation of nuclear noncoding RNAs in mammalian cultured cells[J]. Rna-A Publication Of The Rna Society, 2009, 15(8):1578-1587. doi: 10.1261/rna.1657609 [30] Arun G, Diermeier S, Akerman M, et al. Differentiation of mammary tumors and reduction in metastasis upon Malat1 LncRNA loss[J]. Cancer Res, 2016, 76(6):34-51. https://www.researchgate.net/publication/288001120_Differentiation_of_mammary_tumors_and_reduction_in_metastasis_upon_Malat1_lncRNA_loss -
下载:
点击查看大图
图(1)
计量
- 文章访问数: 72
- HTML全文浏览量: 41
- PDF下载量: 2
- 被引次数: 0
